Protagonist Therapeutics, Inc. (PTGX)
154.70
+0.38
(+0.25%)
USD |
NASDAQ |
Aug 24, 16:00
154.70
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Price to Book Value : 11.89 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 11.86 |
| August 20, 2026 | 11.58 |
| August 19, 2026 | 11.91 |
| August 18, 2026 | 12.09 |
| August 17, 2026 | 12.19 |
| August 14, 2026 | 11.92 |
| August 13, 2026 | 11.64 |
| August 12, 2026 | 11.68 |
| August 11, 2026 | 11.40 |
| August 10, 2026 | 11.53 |
| August 07, 2026 | 11.21 |
| August 06, 2026 | 11.23 |
| August 05, 2026 | 10.55 |
| August 04, 2026 | 10.44 |
| August 03, 2026 | 10.17 |
| July 31, 2026 | 10.50 |
| July 30, 2026 | 10.65 |
| July 29, 2026 | 10.22 |
| July 28, 2026 | 10.52 |
| July 27, 2026 | 10.42 |
| July 24, 2026 | 10.46 |
| July 23, 2026 | 10.41 |
| July 22, 2026 | 10.41 |
| July 21, 2026 | 10.63 |
| July 20, 2026 | 10.32 |
| Date | Value |
|---|---|
| July 17, 2026 | 10.83 |
| July 16, 2026 | 10.15 |
| July 15, 2026 | 10.41 |
| July 14, 2026 | 10.09 |
| July 13, 2026 | 9.982 |
| July 10, 2026 | 10.10 |
| July 09, 2026 | 10.58 |
| July 08, 2026 | 10.76 |
| July 07, 2026 | 10.82 |
| July 06, 2026 | 10.11 |
| July 02, 2026 | 10.11 |
| July 01, 2026 | 9.619 |
| June 30, 2026 | 9.420 |
| June 29, 2026 | 11.92 |
| June 26, 2026 | 11.94 |
| June 25, 2026 | 12.02 |
| June 24, 2026 | 11.97 |
| June 23, 2026 | 11.66 |
| June 22, 2026 | 11.27 |
| June 18, 2026 | 11.06 |
| June 17, 2026 | 10.92 |
| June 16, 2026 | 10.84 |
| June 15, 2026 | 11.02 |
| June 12, 2026 | 10.76 |
| June 11, 2026 | 10.76 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 15.40 |
| Insmed, Inc. | 35.74 |
| Madrigal Pharmaceuticals, Inc. | 22.57 |
| AbbVie, Inc. | -- |
| PTC Therapeutics, Inc. | -- |
Price to Book Value Related Metrics
| PE Ratio | 149.18 |
| PS Ratio | 36.93 |
| PEG Ratio | 3.276 |
| Price to Free Cash Flow | 79.76 |
| Price | 154.70 |
| Earnings Yield | 0.67% |
| Market Cap | 10.00B |
| PEGY Ratio | 3.276 |
| Operating PE Ratio | 178.52 |
| Normalized PE Ratio | 149.17 |